Alzamend Neuro Stock Probability of Future Stock Price Finishing Over 4.95
| ALZN Stock | USD 1.26 0.03 2.33% |
Alzamend |
Alzamend Neuro Target Price Odds to finish over 4.95
The tendency of Alzamend Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 4.95 or more in 90 days |
| 1.26 | 90 days | 4.95 | near 1 |
Based on a normal probability distribution, the odds of Alzamend Neuro to move over $ 4.95 or more in 90 days from now is near 1 (This Alzamend Neuro probability density function shows the probability of Alzamend Stock to fall within a particular range of prices over 90 days) . Probability of Alzamend Neuro price to stay between its current price of $ 1.26 and $ 4.95 at the end of the 90-day period is about 91.83 .
Given the investment horizon of 90 days Alzamend Neuro has a beta of -0.21. This suggests as returns on the benchmark increase, returns on holding Alzamend Neuro are expected to decrease at a much lower rate. During a bear market, however, Alzamend Neuro is likely to outperform the market. Additionally Alzamend Neuro has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Alzamend Neuro Price Density |
| Price |
Predictive Modules for Alzamend Neuro
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alzamend Neuro. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Alzamend Neuro Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Alzamend Neuro is not an exception. The market had few large corrections towards the Alzamend Neuro's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alzamend Neuro, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alzamend Neuro within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.1 | |
β | Beta against Dow Jones | -0.21 | |
σ | Overall volatility | 0.33 | |
Ir | Information ratio | -0.32 |
Alzamend Neuro Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alzamend Neuro for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alzamend Neuro can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alzamend Neuro generated a negative expected return over the last 90 days | |
| Alzamend Neuro may become a speculative penny stock | |
| Alzamend Neuro has high historical volatility and very poor performance | |
| Alzamend Neuro has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.95 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alzamend Neuro currently holds about 11.53 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Alzamend Neuro has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Alzamend Neuro Announces Full Data Set from its Nonclinical Study Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimers Transgenic Mice |
Alzamend Neuro Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alzamend Stock often depends not only on the future outlook of the current and potential Alzamend Neuro's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alzamend Neuro's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 676.6 K | |
| Cash And Short Term Investments | 376 K |
Alzamend Neuro Technical Analysis
Alzamend Neuro's future price can be derived by breaking down and analyzing its technical indicators over time. Alzamend Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alzamend Neuro. In general, you should focus on analyzing Alzamend Stock price patterns and their correlations with different microeconomic environments and drivers.
Alzamend Neuro Predictive Forecast Models
Alzamend Neuro's time-series forecasting models is one of many Alzamend Neuro's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alzamend Neuro's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Alzamend Neuro
Checking the ongoing alerts about Alzamend Neuro for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alzamend Neuro help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Alzamend Neuro generated a negative expected return over the last 90 days | |
| Alzamend Neuro may become a speculative penny stock | |
| Alzamend Neuro has high historical volatility and very poor performance | |
| Alzamend Neuro has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.95 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alzamend Neuro currently holds about 11.53 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Alzamend Neuro has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Alzamend Neuro Announces Full Data Set from its Nonclinical Study Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimers Transgenic Mice |
Check out Alzamend Neuro Backtesting, Alzamend Neuro Valuation, Alzamend Neuro Correlation, Alzamend Neuro Hype Analysis, Alzamend Neuro Volatility, Alzamend Neuro History as well as Alzamend Neuro Performance. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (142.87) | Return On Assets (2.14) | Return On Equity (44.08) |
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.